Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acidity suppresses CD8 + T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling. | EMBO J | 2024 | 39284912 | PubTator, text mining | PubMed |
| Paeoniflorin inhibits PRAS40 interaction with Raptor to activate mTORC1 to reverse excessive autophagy in airway epithelial cells for asthma. | Phytomedicine | 2024 | 39276538 | PubTator, text mining | PubMed |
| Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer. | Cancer Lett | 2024 | 39244005 | PubTator, text mining | PubMed |
| Plant-based proteins: clinical and technological importance. | Food Sci Biotechnol | 2024 | 39144188 | PubTator, text mining | PubMed |
| Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage. | Stem Cell Res Ther | 2024 | 39075600 | PubTator, text mining | PubMed |
| High glucose-induced downregulation of PTEN-Long is sufficient for proximal tubular cell injury in diabetic kidney disease. | Exp Cell Res | 2024 | 38830568 | PubTator, text mining | PubMed |
| Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease. | Mol Neurobiol | 2024 | 38816674 | PubTator, text mining | PubMed |
| Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma. | Int J Mol Sci | 2024 | 38612399 | PubTator, text mining | PubMed |
| Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse Glioma. | Mod Pathol | 2024 | 38588881 | PubTator, text mining | PubMed |
| Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations. | Cancer Discov | 2024 | 38456804 | PubTator, text mining | PubMed |
| A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors. | Cancer Chemother Pharmacol | 2024 | 38411735 | PubTator, text mining | PubMed |
| Schwann cell derived pleiotrophin stimulates fibroblast for proliferation and excessive collagen deposition in plexiform neurofibroma. | Cancer Gene Ther | 2024 | 38302728 | PubTator, text mining | PubMed |
| FGF21-mediated autophagy: Remodeling the homeostasis in response to stress in liver diseases. | Genes Dis | 2024 | 38292187 | PubTator, text mining | PubMed |
| Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer. | bioRxiv | 2024 | 38260423 | PubTator, text mining | PubMed |
| A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma. | Biomedicines | 2024 | 38255303 | PubTator, text mining | PubMed |
| Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases. | Biology (Basel) | 2024 | 38248465 | PubTator, text mining | PubMed |
| Hypoxia-Inducible Factor and Oxidative Stress in Tendon Degeneration: A Molecular Perspective. | Antioxidants (Basel) | 2024 | 38247510 | PubTator, text mining | PubMed |
| Tumor cell-intrinsic PD-1 promotes Merkel cell carcinoma growth by activating downstream mTOR-mitochondrial ROS signaling. | Sci Adv | 2024 | 38241371 | PubTator, text mining | PubMed |
| The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. | Chem Sci | 2024 | 38239681 | PubTator, text mining | PubMed |
| Amino acid metabolism in tumor biology and therapy. | Cell Death Dis | 2024 | 38218942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=3